Market Overview:
The global glass sterile vials market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for glass sterile vials from clinical labs, compounding labs, and biopharmaceutical companies. Additionally, the growing demand for these products in emerging markets such as Asia Pacific and Latin America is also contributing to the growth of this market. However, factors such as high cost and limited availability of raw materials are restraining the growth of this market.
Product Definition:
A sterile vial is a container made of glass or plastic that is designed to hold liquids, gels, or powders. It is used to store and transport medications and other medical supplies.
2ml is the smallest size available in glass sterile vials. It’s a type of medical container that is used to store small quantities of liquid or semi-solid products such as vaccines, antibiotics, enzymes and chemicals. They are made from borosilicate glass and have an airtight seal owing to which they can be used for storing drugs for a longer period without any contamination.
2 ml to 5 ml:
2 ml to 5 ml is a range of sterile injectable solutions that are offered in different volumes. The most commonly used 2ml to 5ml vials sizes are for subcutaneous injections and intravenous infusions.
The glass 2ml to 5 ml vials come with either polypropylene or PVC caps, depending on the preference of the manufacturer.
Application Insights:
Based on application, the global glass sterile vials market is segmented into clinical, compounded and biopharmaceutical companies. The others application segment includes research laboratories and hospitals. The clinical applications include hospital-based as well as private clinics. Increasing number of patients at private clinics has led to an increased demand for glass sterilized vials over the past few years in this region.
The compounded drugs are mainly used in homeopathy and other alternative medicine treatments where a single dose contains from 5 to 20000 times the strength of the original drug substance; therefore, these types of medicines need very small quantities (less than 10 ml) each time they are prepared or manufactured so that even if there is some error during preparation or manufacturing process, it will not have any harmful effects on patients due to lack of proper dosage accuracy.
Regional Analysis:
North America dominated the global glass sterile vials market in 2017. The presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare expenditure in North America compared to other regions are some factors attributing towards its large share.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government initiatives for developing a strong pharmaceutical industry and improving healthcare facilities in emerging countries such as China and India. In addition, rising disposable income coupled with growing demand for generic drugs will also support regional growth during the forecast period.
Growth Factors:
- Increasing demand for sterile vials in the pharmaceutical and biotechnology industries due to the growing prevalence of chronic diseases and increasing R&D expenditure by these industries.
- Rising demand for glass sterile vials from emerging markets such as China, India, Brazil, and Mexico due to the growth of their respective pharmaceutical and biotechnology industries.
- Technological advancements in glass sterilization techniques that have resulted in improved product quality and reduced manufacturing costs.
- Growing preference for glass over plastic sterile vials among end users owing to its superior chemical resistance properties and non-toxicity characteristics.
Scope Of The Report
Report Attributes
Report Details
Report Title
Glass Sterile Vials Market Research Report
By Type
<2ml, 2 ml to 5 ml, 5 ml to 10 ml, 10 ml to 20 ml, >20ml
By Application
Clinical Labs, Compounding Labs, Biopharmaceutical Companies, Others
By Companies
Adelphi Healthcare Packaging, APG Europe, Bormioli Pharma, Corning Incorporated, Dalton Pharma Services, DWK Life Sciences GmbH, Gerresheimer, Nipro Corporation, O.Berk Company, Pacific Vial, Piramal Glass (Piramal Enterprises Ltd.), Schott, SDG Pharma, Shandong Pharmaceutical Glass, SiO2 Materials Science, Stevanato Group, Thermo Fisher Scientific, West Pharmaceutical Services
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Glass Sterile Vials Market Report Segments:
The global Glass Sterile Vials market is segmented on the basis of:
Types
<2ml, 2 ml to 5 ml, 5 ml to 10 ml, 10 ml to 20 ml, >20ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Labs, Compounding Labs, Biopharmaceutical Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adelphi Healthcare Packaging
- APG Europe
- Bormioli Pharma
- Corning Incorporated
- Dalton Pharma Services
- DWK Life Sciences GmbH
- Gerresheimer
- Nipro Corporation
- O.Berk Company
- Pacific Vial
- Piramal Glass (Piramal Enterprises Ltd.)
- Schott
- SDG Pharma
- Shandong Pharmaceutical Glass
- SiO2 Materials Science
- Stevanato Group
- Thermo Fisher Scientific
- West Pharmaceutical Services
Highlights of The Glass Sterile Vials Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- <2ml
- 2 ml to 5 ml
- 5 ml to 10 ml
- 10 ml to 20 ml
- >20ml
- By Application:
- Clinical Labs
- Compounding Labs
- Biopharmaceutical Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glass Sterile Vials Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glass sterile vials are used to store medications and other medical products. They are made of high-quality, durable glass that is free from harmful chemicals. This makes them a safe option for storing medication, and they can be easily sealed to keep contents safe.
Some of the major players in the glass sterile vials market are Adelphi Healthcare Packaging, APG Europe, Bormioli Pharma, Corning Incorporated, Dalton Pharma Services, DWK Life Sciences GmbH, Gerresheimer, Nipro Corporation, O.Berk Company, Pacific Vial, Piramal Glass (Piramal Enterprises Ltd.), Schott, SDG Pharma, Shandong Pharmaceutical Glass, SiO2 Materials Science, Stevanato Group, Thermo Fisher Scientific, West Pharmaceutical Services.
The glass sterile vials market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glass Sterile Vials Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glass Sterile Vials Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glass Sterile Vials Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glass Sterile Vials Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glass Sterile Vials Market Size & Forecast, 2018-2028
4.5.1 Glass Sterile Vials Market Size and Y-o-Y Growth
4.5.2 Glass Sterile Vials Market Absolute $ Opportunity
Chapter 5 Global Glass Sterile Vials Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Glass Sterile Vials Market Size Forecast by Type
5.2.1 <2ml
5.2.2 2 ml to 5 ml
5.2.3 5 ml to 10 ml
5.2.4 10 ml to 20 ml
5.2.5 >20ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Glass Sterile Vials Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Glass Sterile Vials Market Size Forecast by Applications
6.2.1 Clinical Labs
6.2.2 Compounding Labs
6.2.3 Biopharmaceutical Companies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glass Sterile Vials Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glass Sterile Vials Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Glass Sterile Vials Analysis and Forecast
9.1 Introduction
9.2 North America Glass Sterile Vials Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Glass Sterile Vials Market Size Forecast by Type
9.6.1 <2ml
9.6.2 2 ml to 5 ml
9.6.3 5 ml to 10 ml
9.6.4 10 ml to 20 ml
9.6.5 >20ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Glass Sterile Vials Market Size Forecast by Applications
9.10.1 Clinical Labs
9.10.2 Compounding Labs
9.10.3 Biopharmaceutical Companies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Glass Sterile Vials Analysis and Forecast
10.1 Introduction
10.2 Europe Glass Sterile Vials Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Glass Sterile Vials Market Size Forecast by Type
10.6.1 <2ml
10.6.2 2 ml to 5 ml
10.6.3 5 ml to 10 ml
10.6.4 10 ml to 20 ml
10.6.5 >20ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Glass Sterile Vials Market Size Forecast by Applications
10.10.1 Clinical Labs
10.10.2 Compounding Labs
10.10.3 Biopharmaceutical Companies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Glass Sterile Vials Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Glass Sterile Vials Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Glass Sterile Vials Market Size Forecast by Type
11.6.1 <2ml
11.6.2 2 ml to 5 ml
11.6.3 5 ml to 10 ml
11.6.4 10 ml to 20 ml
11.6.5 >20ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Glass Sterile Vials Market Size Forecast by Applications
11.10.1 Clinical Labs
11.10.2 Compounding Labs
11.10.3 Biopharmaceutical Companies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Glass Sterile Vials Analysis and Forecast
12.1 Introduction
12.2 Latin America Glass Sterile Vials Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Glass Sterile Vials Market Size Forecast by Type
12.6.1 <2ml
12.6.2 2 ml to 5 ml
12.6.3 5 ml to 10 ml
12.6.4 10 ml to 20 ml
12.6.5 >20ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Glass Sterile Vials Market Size Forecast by Applications
12.10.1 Clinical Labs
12.10.2 Compounding Labs
12.10.3 Biopharmaceutical Companies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Glass Sterile Vials Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Glass Sterile Vials Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Glass Sterile Vials Market Size Forecast by Type
13.6.1 <2ml
13.6.2 2 ml to 5 ml
13.6.3 5 ml to 10 ml
13.6.4 10 ml to 20 ml
13.6.5 >20ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Glass Sterile Vials Market Size Forecast by Applications
13.10.1 Clinical Labs
13.10.2 Compounding Labs
13.10.3 Biopharmaceutical Companies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glass Sterile Vials Market: Competitive Dashboard
14.2 Global Glass Sterile Vials Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Adelphi Healthcare Packaging
14.3.2 APG Europe
14.3.3 Bormioli Pharma
14.3.4 Corning Incorporated
14.3.5 Dalton Pharma Services
14.3.6 DWK Life Sciences GmbH
14.3.7 Gerresheimer
14.3.8 Nipro Corporation
14.3.9 O.Berk Company
14.3.10 Pacific Vial
14.3.11 Piramal Glass (Piramal Enterprises Ltd.)
14.3.12 Schott
14.3.13 SDG Pharma
14.3.14 Shandong Pharmaceutical Glass
14.3.15 SiO2 Materials Science
14.3.16 Stevanato Group
14.3.17 Thermo Fisher Scientific
14.3.18 West Pharmaceutical Services
